BioTrinity 2015 confirmed its position as Europe’s leading investment and biopartnering conference, with 953 delegates participating, building on its growing momentum and success in the sector.
For the second time in London, hundreds of delegates from across Europe and a record number of investors flocked to network and do business. BioTrinity continues to provide the best opportunity to meet senior licensing executives from global pharma organisations and senior management of innovative drug development and platform technology companies, many of whom present in the company showcase tracks. Keynotes and expert panellists focused on the resurgence in Life Sciences funding and examined key industry themes and challenges. The event extended reach in medtech with a dedicated MediTrinity programme session which was well received by companies and investors.
If you wish to be kept up to date with plans for the 10th anniversary for BioTrinity April 25 – 27 2016, please email [email protected].
Thanks to EBD Group's partneringONE®, the industry gold-standard partnering system with entirely private partnering:
You need to upgrade your Flash Player
The "Event of the Year" - BioTrinity 2015:
Huge partnering potential with global pharma / investors
100+ presentations by hand-picked R&D companies
Innovative "Connect for Growth" zones that encouraged informal and formal collaborative interactions
Great networking opportunities with 950+ delegates
First class venue at Novotel London West
Exciting Social Programme:
The Big London Networking Party, BioTrinity Welcome Reception and Connect for Drinks
Europe's Largest Investor-only Dinner